Afficher la notice abrégée

dc.contributor.authorGómez Marcos, Manuel Ángel 
dc.contributor.authorPatino Alonso, María Carmen 
dc.contributor.authorRecio Rodríguez, José Ignacio 
dc.contributor.authorAgudo Conde, Cristina
dc.contributor.authorRomaguera-Bosch, Montserrat
dc.contributor.authorMagdalena-Gonzalez, Olga
dc.contributor.authorGomez-Arranz, Amparo
dc.contributor.authorMendizabal-Gallastegui, Nere
dc.contributor.authorFernandez-Diez, Jose Angel
dc.contributor.authorGómez Sánchez, Leticia
dc.contributor.authorMaderuelo Fernández, José A.
dc.contributor.authorRodríguez Sánchez, Emiliano 
dc.contributor.authorGarcía Ortiz, Luis 
dc.date.accessioned2024-01-31T16:03:21Z
dc.date.available2024-01-31T16:03:21Z
dc.date.issued2018-08-01
dc.identifier.citationGomez-Marcos, M. A., Patino-Alonso, M. C., Recio-Rodriguez, J. I., Agudo-Conde, C., Romaguera-Bosch, M., Magdalena-Gonzalez, O., ... & Garcia-Ortiz, L. (2018). Short-and long-term effectiveness of a smartphone application for improving measures of adiposity: a randomised clinical trial–EVIDENT II study. European Journal of Cardiovascular Nursing, 17(6), 552-562. https://doi.org/10.1177/1474515118761870es_ES
dc.identifier.issn1474-5151
dc.identifier.urihttp://hdl.handle.net/10366/155118
dc.description.abstract[EN]Background: Evidence on the efficacy of smartphone applications (apps) for reducing body weight and other measurements of adiposity sustainably is not conclusive. Objective: To evaluate the effect of adding an app for 3 months to traditional counselling on physical activity (PA) and a heart-healthy diet for the modification of measurements of adiposity at 3 and 12 months after intervention. Methods: This randomised clinical trial included 833 subjects. The counselling and app group (IG) had 415 subjects, while 418 were included in the counselling only group (CG). The primary outcome was adiposity measurements at 3 and 12 months after intervention. The secondary outcome was the effect of the intervention by sex. Intervention: Counselling on a heart-healthy diet and PA was given to both groups. The IG also received training in the use of a smartphone app designed to promote a heart-healthy diet and PA, and this group was given access to this application for 3 months. Outcome measurements included waist circumference (WC), body mass index (BMI) and Clínica Universidad de Navarra – body adiposity estimator (CUN-BAE). Results: In the IG at 12 months, the following decreased: WC −0.72 cm (95% confidence interval [CI]: −2.35 to −0.02) and CUN-BAE −0.35 (95% CI: −0.63 to −0.06). These decreases were only observed in women. After baseline adjustment, the beneficial effect was maintained in the IG compared to the CG at 12 months in terms of WC (−0.67; 95% CI: −0.29 to −0.02) and CUNBAE (−0.57; 95% CI: −1.10 to −0.04), but only in women. Conclusions: An intervention of nutritional counselling and PA plus the smartphone app with personalised recommendations compared to CG showed beneficial results in terms of reduction of abdominal obesity and the percentage of body fat in women, but not in men.es_ES
dc.description.sponsorshipThis study was funded by the Spanish Ministry of Science and Innovation (MICINN), the Carlos III Health Institute/European Regional Development Fund (ERDF) (MICINN, ISCIII/FEDER) (FIS: PI13/00618, PI13/01526, PI13/00058, PI13/01635, PI13/02528, PI12/01474; RETICS: RD12/0005, RD16/0007, RD12/0005/0001) and the Regional Health Management of Castilla and León (GRS 1191/B/15, GRS 909/B/14, GRS 770/B/13).es_ES
dc.language.isoenges_ES
dc.publisherOxford Academices_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectPhysical activityes_ES
dc.subjectBody mass indexes_ES
dc.subjectWaist circumferencees_ES
dc.subjectFat mass percentes_ES
dc.subjectmHealthes_ES
dc.subjectInformation communication technologieses_ES
dc.subjectHeart healthy dietes_ES
dc.subject.meshBody Mass Index *
dc.subject.meshWaist Circumference *
dc.titleShort- and long-term effectiveness of a smartphone application for improving measures of adiposity: A randomised clinical trial – EVIDENT II studyes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.1177/1474515118761870es_ES
dc.identifier.doi10.1177/1474515118761870
dc.relation.projectIDPI13/00618,es_ES
dc.relation.projectIDPI13/01526es_ES
dc.relation.projectIDPI13/00058es_ES
dc.relation.projectIDPI13/01635es_ES
dc.relation.projectIDPI13/02528es_ES
dc.relation.projectIDPI12/01474es_ES
dc.relation.projectIDGRS 1191/B/15es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/embargoedAccesses_ES
dc.identifier.essn1873-1953
dc.journal.titleEuropean Journal of Cardiovascular Nursinges_ES
dc.volume.number17es_ES
dc.issue.number6es_ES
dc.page.initial552es_ES
dc.page.final562es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decsíndice de masa corporal *
dc.subject.decsperímetro abdominal *


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 Internacional